Koji Matsuo
Papers
10
Total Citations
225
H-Index
6
About
Koji Matsuo is a leading gynecologic oncologist whose research is reshaping surgical care for women with gynecologic malignancies. His work centers on three critical areas: optimizing postoperative thromboprophylaxis, advancing minimally invasive surgery (MIS), and improving perioperative outcomes through volume-based care. His landmark 2020 study on apixaban versus enoxaparin for preventing venous thromboembolism after gynecologic cancer surgery (133 citations) challenged standard practice by demonstrating the safety and efficacy of a more accessible, cost-effective alternative—directly addressing low adherence and high costs associated with traditional enoxaparin regimens. Matsuo has also been instrumental in evaluating the role of MIS in complex procedures, including a national study on minimally invasive pelvic exenteration (29 citations) and a meta-analysis comparing MIS to open laparotomy for epithelial ovarian cancer (15 citations). His work on volume-outcome relationships in radical hysterectomy (21 citations) underscores the importance of surgical expertise in early-stage cervical cancer. With over 200 publications, Matsuo’s research consistently bridges evidence and practice, offering actionable insights that improve survival, reduce complications, and enhance quality of life for women facing gynecologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7A cesarean delivery sequela:4 citations · 2020
- 8
- 9
- 10